ArticleNanomaterials (Basel, Switzerland)2025
Antibacterial Potential of Nanocrystalline Zinc-Cobalt Ferrite.
Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent Advances in Ferrite-Based Materials for Biomedical Applications: A Comprehensive Review.Advanced materials (Deerfield Beach, Fla.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe synthesis of nanoscale particles with antibacterial properties has garnered significant attention in pharmaceutical research, driven by the escalating threat of antibiotic-resistant bacteria. This study investigates the antibacterial efficacy of Zn-Co ferrite nanoparticles against virulent, antibiotic-resistant, and biofilm-forming strains of
resultsThe SEM spectroscopy study revealed distinct morphological differences as a function of the cobalt substitution level within the spinel ferrite matrix. At the highest level of cobalt substitution (Zn
conclusionIncreasing the molar ratio of Zn to Co enhances the antibacterial activity of the nanoparticles. These findings suggest that Zn-Co ferrite nanoparticles could serve as a promising alternative to conventional antibacterial agents for combating multidrug-resistant pathogenic bacteria in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.